KCNMB Antibodies

Santa Cruz Biotechnology features a diverse variety of KCNMB monoclonal antibodies for studying potassium channel modulatory beta subunits. KCNMB monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KCNMB proteins play a crucial role in the regulation of potassium channels, influencing smooth muscle contraction and neuronal excitability. The function of KCNMB proteins is essential for maintaining cellular homeostasis and has implications in cardiovascular health and neurological disorders. Understanding KCNMB proteins can provide insights into potential therapeutic targets for various diseases. Research focused on KCNMB proteins continues to reveal new aspects of ion channel regulation and cellular signaling pathways. Investigating KCNMB expression patterns helps scientists better understand tissue-specific functions and disease mechanisms. Current studies of KCNMB are uncovering promising therapeutic approaches for treating cardiovascular and neurological conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of potassium channel biology and its impact on human health.